Filing Details

Accession Number:
0000899243-23-012008
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-02 18:29:41
Reporting Period:
2023-05-01
Accepted Time:
2023-05-02 18:29:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430466 H Waleed Hassanein C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-01 5,406 $77.84 561,285 No 4 S Direct
Common Stock Disposition 2023-05-01 1,759 $78.65 559,526 No 4 S Direct
Common Stock Disposition 2023-05-01 335 $80.12 559,191 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 14, 2022.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $77.29 to $78.27, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $78.29 to $79.14, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $79.72 to $80.42, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.